Metabolic aspects of critical illness polyneuromyopathy

Critical Care Medicine

Volumn 37, Issue SUPPL. 10, 2009, Pages

  Hermans, Greet ^a,b   Vanhorebeek, Ilse ^a,b   Derde, Sarah ^a,b   Van Den Berghe, Greet ^a,b  

^a Medical Intensive Care Unit   (Belgium)

^b LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

Critical illness; Glucose; Heuropathy; Insulin; Intensive care; Metabolic; Myopathy; Pathophysiology; Polyneuromyopathy; Weakness

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ARGININE; DROTRECOGIN; GLUTAMINE; INSULIN; TUMOR NECROSIS FACTOR ANTIBODY;

ARTIFICIAL VENTILATION; CONFERENCE PAPER; CRITICAL ILLNESS; CRITICAL ILLNESS POLYNEUROMYOPATHY; CRITICALLY ILL PATIENT; DECUBITUS; DIET SUPPLEMENTATION; EXCITATION CONTRACTION COUPLING; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOXIA; IMMUNOMODULATION; INSULIN RESISTANCE; INSULIN TREATMENT; MUSCLE CONTRACTURE; MUSCLE FIBER MEMBRANE; MUSCLE FORCE; NEUROMUSCULAR DISEASE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REHABILITATION CARE; SEPSIS;

EID: 70350493303     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b6f01a     Document Type: Conference Paper

References (98)

1. Maramattom BV, Wijdicks EF: Acute neuromuscular weakness in the intensive care unit. Crit Care Med 2006; 34:2835-2841 (Pubitemid 44610951)
2. Bednarik J, Lukas Z, Vondracek P: Critical illness polyneuromyopathy: The electrophysiological components of a complex entity. Intensive Care Med 2003; 29:1505-1514 (Pubitemid 37153595)
3. Latronico N, Fenzi F, Recupero D, et al: Critical illness myopathy and neuropathy. Lancet 1996; 347:1579-1582
4. Stevens RD, Dowdy DW, Michaels RK, et al: Neuromuscular dysfunction acquired in critical illness: A systematic review. Intensive Care Med 2007; 33:1876-1891
5. Leijten FS, Harinck-de Weerd JE, Poortvliet DC, et al: The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995; 274:1221-1225
6. Garnacho-Montero J, Madrazo-Osuna J, Garcia-Garmendia JL, et al: Critical illness polyneuropathy: Risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001; 27:1288-1296 (Pubitemid 32758926)
7. Garnacho-Montero J, Amaya-Villar R, GarciaGarmendia JL, et al: Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 2005; 33: 349-354 (Pubitemid 40216548)
8. Nanas S, Kritikos K, Angelopoulos E, et al: Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit. Acta Neurol Scand 2008; 118: 175-181
9. Latronico N, Bertolini G, Guarneri B, et al: Simplified electrophysiological evaluation of peripheral nerves in critically ill patients: The Italian multi-centre CRIMYNE study. Crit Care 2007; 11:R11 (Pubitemid 46351114)
10. Herridge MS, Cheung AM, Tansey CM, et al: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348:683-693 (Pubitemid 36237037)
11. DeSezeM,PetitH,WiartL,etal:Criticalillnesspolyneuropathy. A2-yearfollow-upstudyin19severecases.EurNeurol2000;43:61-69(Pubitemid30114094)
12. Bolton CF: Neuromuscular manifestations of critical illness. Muscle Nerve 2005; 32: 140-163
13. FenziF,LatronicoN,RefattiN,etal:EnhancedexpressionofE- selectinonthevascularendotheliumof peripheralnerveincriticallyillpatientswithneuromusculardisorders. ActaNeuropathol(Berl)2003;106:75-82(Pubitemid36806170)
14. Druschky A, Herkert M, Radespiel-Troger M, et al: Critical illness polyneuropathy: Clinical findings and cell culture assay of neurotoxicity assessed by a prospective study. Intensive Care Med 2001; 27:686-693 (Pubitemid 32318330)
15. Z'Graggen WJ, Lin CS, Howard RS, et al: Nerve excitability changes in critical illness polyneuropathy. Brain 2006; 129:2461-2470 (Pubitemid 44522130)
16. Rich MM, Pinter MJ: Crucial role of sodium channel fast inactivation in muscle fibre inexcitability in a rat model of critical illness myopathy. J Physiol 2003; 547:555-566
17. Filatov GN, Rich MM: Hyperpolarized shifts in the voltage dependence of fast inactivation of Navl.4 and Navl.5 in a rat model of critical illness myopathy. J Physiol 2004; 559: 813-820
18. Teener JW, Rich MM: Dysregulation of sodium channel gating in critical illness myopathy. J Muscle Res Cell Motil 2006; 27: 291-296
19. Capasso M, Di Muzio A, Pandolfi A, et al: Possible role for nitric oxide dysregulation in critical illness myopathy. Muscle Nerve 2008; 37:196-202 (Pubitemid 351214166)
20. Van den Berghe G: How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004; 114:1187-1195 (Pubitemid 40385286)
21. Rossignol B, Gueret G, Pennec JP, et al: Effects of chronic sepsis on contractile properties of fast twitch muscle in an experimental model of critical illness neuromyopathy in the rat. Crit Care Med 2008; 36:1855-1863
22. Young GB: Critical illness myopathy: Deeper insights. Crit Care Med 2008; 36:1977
23. Friedrich O, Hund E, Weber C, et al: Critical illness myopathy serum fractions affect membrane excitability and intracellular calcium release in mammalian skeletal muscle. J Neurol 2004; 251:53-65 (Pubitemid 38210490)
24. Verheul GA, Jongh-Leuvenink J, Op de Coul AA, et al: Tumor necrosis factor and interleukin-6 in critical illness polyneuromyopathy. Clin Neurol Neurosurg 1994; 96: 300-304 (Pubitemid 24357061)
25. TraceyKJ,LowrySF,BeutlerB,etal:Cachectin/ tumornecrosisfactormediateschangesofskeletalmuscleplasmamembranepotential. JExpMed1986;164:1368-1373(Pubitemid16031632)
26. TiaoG,HoblerS,WangJJ,etal: SepsisisassociatedwithincreasedmRNAsoftheubiquitin- proteasomeproteolyticpathwayinhumanskeletalmuscle.JClinInvest1997;99: 163-168(Pubitemid27053458)
27. Klaude M, Fredriksson K, Tjader I, et al: Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sei (Land) 2007; 112:499-506 (Pubitemid 46762011)
28. Showalter CJ, Engel AG: Acute quadriplegic myopathy: Analysis of myosin isoforms and evidence for calpain-mediated proteolysis. Muscle Nerve 1997; 20:316-322
29. Biolo G, Fleming RY, Maggi SP, et al: Inverse regulation of protein turnover and amino acid transport in skeletal muscle of hypercatabolic patients. J Clin Endocrinol Metab 2002; 87:3378-3384 (Pubitemid 34816392)
30. DiGiovanniS,MirabellaM,D'AmicoA,etal: Apoptoticfeaturesaccompanyacutequadriplegicmyopathy.Neurology2000;55: 854-858(Pubitemid30727728)
31. Di Giovanni S, Molon A, Broccolini A, et al: Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol 2004; 55:195-206 (Pubitemid 38166996)
32. Frost RA, Lang CH: Regulation of muscle growth by pathogen-associated molecules. J Anim Sd 2008; 86:E84-E93
33. Zamir O, Hasselgren PO, Kunkel SL, et al: Evidence that tumor necrosis factor participates in the regulation of muscle proteolysis during sepsis. Arch Surg 1992; 127:170-174
34. Reid MB, Lannergren J, Westerblad H: Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: Involvement of muscle myofilaments. Am J Respir Crit Care Med 2002; 166:479-484 (Pubitemid 34895432)
35. de Letter MA, van Doom PA, Savelkoul HF, et al: Critical illness polyneuropathy and myopathy (CIPNM): Evidence for local immune activation by cytokine-expression in the muscle tissue. J Neuroimmunol 2000; 106: 206-213
36. Lang CH, Hong-Brown L, Frost RA: Cytokine inhibition of JAK-STAT signaling: A new mechanism of growth hormone resistance. Pediatr Nephrol 2005; 20:306-312 (Pubitemid 40309934)
37. Mizock BA: Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 1995; 98:75-84
38. FerrandoAA,StuartCA,Sheffield-MooreM,etal: Inactivityamplifiesthecatabolicresponseofskeletalmuscle-Cortisol. JClinEndocrinolMetab1999;84:3515-3521(Pubitemid30645199)
39. TiaoG,FaganJ,RoegnerV,etal:Energyubiquitin- dependentmuscleproteolysisduringsepsisinratsisregulatedbyglucocorticoids. JClinInvest1996;97:339-348(Pubitemid26039396)
40. Kelly FJ, McGrath JA, Goldspink DF, et al: A morphological/biochemical study on the actions of corticosteroids on rat skeletal muscle. Muscle Nerve 1986; 9:1-10
41. Lee MC, Wee GR, Kim JH: Apoptosis of skeletal muscle on steroid-induced myopathy in rats. J Nutr 2005, 135:1806S-1808S
42. Macdonald J, Galley HF, Webster NR: Oxidative stress and gene expression in sepsis. BrJ Anaesth 2003; 90:221-232 (Pubitemid 36181968)
43. Flaring UB, Rooyackers OE, Hebert C, et al: Temporal changes in whole-blood and plasma glutathione in ICU patients with multiple organ failure. Intensive Care Med 2005; 31:1072-1078 (Pubitemid 41125338)
44. Hammarqvist F, Luo JL, Cotgreave IA, et al: Skeletal muscle glutathione is depleted in critically ill patients. Crit Care Med 1997; 25:78-84 (Pubitemid 27015043)
45. Brealey D, Brand M, Hargreaves I, et al: Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223 (Pubitemid 34804650)
46. BarrientosA,MoraesCT: TitratingtheeffectsofmitochondrialcomplexIimpairmentinthecellphysiology. JBiolChem1999;274:16188-16197(Pubitemid129526367)
47. Frost MT, Wang Q, Moneada S, et al: Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. Am J Physiol Regul Integr Comp Physiol 2005; 288:R394-R400 (Pubitemid 40129604)
48. Laghi F, Cattapan SE, Jubran A, et al: Is weaning failure caused by low-frequency fatigue of the diaphragm? Am J Respir Crit Care Med 2003; 167:120-127 (Pubitemid 36076069)
49. Hermans G, De Jonghe B, Bruyninckx F, et al: Interventions for preventing critical illness polyneuropathy and critical illness myopathy. Cochrane Database Syst Rev 2009; 1:CD006832 (Pubitemid 351805263)
50. Bolton CF, Gilbert JJ, Hahn AF, et al: Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47:1223-1231
51. Waldhausen E, Mingers B, Lippers P, et al: Critical illness polyneuropathy due to parenteral nutrition. Intensive Care Med 1997; 23: 922-923
52. Marino PL, Millili JJ: Possible role of dietary lipids in critical illness polyneuropathy. Intensive Care Med 1998; 24:87
53. Kreymann KG, Berger MM, Deutz NE, et al: ESPEN guidelines on enteral nutrition: Intensive care. Clin Nutr 2006; 25:210-223 (Pubitemid 43811686)
54. Marik PE, Zaloga GP: Immunonutrition in critically ill patients: A systematic review and analysis of the literature. Intensive Care Med 2008; 34:1980-1990
55. Tjader I, Rooyackers O, Forsberg AM, et al: Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med 2004; 30:266-275 (Pubitemid 38253418)
56. Mansoor O, Breuille D, Bechereau F, et al: Effect of an enteral diet supplemented with a specific blend of amino acid on plasma and muscle protein synthesis in ICU patients. Clin Nutr 2007; 26:30-40 (Pubitemid 46201493)
57. Heyland DK, Dhaliwal R, Suchner U, et al: Antioxidant nutrients: A systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005; 31: 327-337
58. Heyland DK, Dhaliwal R, Day AG, et al: REducing Deaths due to Oxidative Stress (The REDOXS Study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc Nutr Soc 2006; 65:250-263 (Pubitemid 46323840)
59. Morris PE, Goad A, Thompson C, et al: Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med 2008; 36:2238-2243
60. Needham DM: Mobilizing patients in the intensive care unit: Improving neuromuscular weakness and physical function. JAMA 2008; 300:1685-1690
61. Caruso P, Denari SD, Ruiz SA, et al: Inspiratory muscle training is ineffective in mechanically ventilated critically ill patients. Clinics (Sao Paulo) 2005; 60:479-484
62. Giamarellos-Bourboulis EJ: Immunomodulatory therapies for sepsis: Unexpected effects with macrolides. Int J Antimicrob Agents 2008; 32(Suppl 1):S39-S43
63. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709 (Pubitemid 32204987)
64. Takala J, Ruokonen E, Webster NR, et al: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341:785-792 (Pubitemid 29420473)
65. Taylor BE, Buchman TG: Is there a role for growth hormone therapy in refractory critical illness? Curr Opin Crit Care 2008; 14: 438-444
66. FerrandoAA,Sheffield-MooreM,WolfSE,etal: Testosteroneadministrationinsevereburnsamelioratesmusclecatabolism. CritCareMed2001;29:1936-1942(Pubitemid32980405)
67. Demling RH, Orgill DP: The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care 2000; 15:12-17
68. Wolf SE, Edelman LS, Kemalyan N, et al: Effects of oxandrolone on outcome measures in the severely burned: A multicenter prospective randomized double-blind trial. J Burn Care Res 2006; 27:131-139 (Pubitemid 43970312)
69. DeLetterMA,SchmitzPI,VisserLH,etal: Riskfactorsforthedevelopmentofpolyneuropathyandmyopathyincriticallyillpatients. CritCareMed2001;29:2281-2286(Pubitemid34038159)
70. Bednarik J, Vondracek P, Dusek L, et al: Risk factors for critical illness polyneuromyopathy. J Neurol 2005; 252:343-351 (Pubitemid 40562168)
71. Campellone JV, Lacomis D, Kramer DJ, et al: Acute myopathy after liver transplantation. Neurology 1998; 50:46-53
72. De Jonghe B, Sharshar T, Lefaucheur JP, et al: Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002; 288:2859-2867 (Pubitemid 35425072)
73. Hough CL, Steinberg KP, Taylor TB, et al: Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med 200; 35:63-68
74. Hermans G, Wilmer A, Meersseman W, et al: Impact of intensive insulin therapy on neuromuscular complications and ventilatordependency in MICU. Am J Respir Crit Care Med 2007; 175:480-489
75. VandenBergheG,SchoonheydtK,BecxP,etal: Insulintherapyprotectsthecentraland peripheralnervoussystemofintensivecarepatients.Neurology2005;64: 1348-1353(Pubitemid40570499)
76. Maes K, Testelmans D, Cadot P, et al: Effects of acute administration of corticosteroids during mechanical ventilation on rat diaphragm. Am J Respir Crit Care Med 2008; 178:1219-1226
77. Nasraway SA Jr: Hyperglycemia during critical illness. JPEN J Parenter Enteral Nutr 2006; 30:254-258
78. Bercker S, Weber-Carstens S, Deja M, et al: Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 2005; 33: 711-715 (Pubitemid 40504376)
79. Witt NJ, Zochodne DW, Bolton CF, et al: Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99:176-184
80. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367 (Pubitemid 34940724)
81. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. J Engl J Med 2006; 354:449-461 (Pubitemid 43200296)
82. Van den Berghe G, Wilmer A, Milants I, et al: Intensive insulin therapy in mixed medical/ surgical intensive care units: Benefit versus harm. Diabetes 2006; 55:3151-3159 (Pubitemid 44923655)
83. Berends N, Hermans G, Bouckaert B, et al: Implementing intensive insulin therapy in daily practice reduces the incidence of critical illness polyneuropathy and/or myopathy. Crit Care 2008; 12(Suppl 2):P155
84. Langouche L, Vanhorebeek I, Vlasselaers D, et al: Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115:2277-2286 (Pubitemid 41134169)
85. Krishnan AV, Kiernan MC: Altered nerve excitability properties in established diabetic neuropathy. Brain 2005; 128:1178-1187 (Pubitemid 40675471)
86. Krishnan AV, Lin CS, Kiernan MC: Activitydependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy. Brain 2008; 131:1209-1216
87. Kitano Y, Kuwabara S, Misawa S, et al: The acute effects of glycemic control on axonal excitability in human diabetics. Ann Neurol 2004; 56:462-467 (Pubitemid 39319335)
88. Henrich M, Paddenberg R, Haberberger RV, et al: Hypoxic increase in nitric oxide generation of rat sensory neurons requires activation of mitochondrial complex II and voltage-gated calcium channels. Neuroscience 2004; 128:337-345 (Pubitemid 39200480)
89. Vanhorebeek I, De Vos R, Mesotten D, et al: Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365:53-59 (Pubitemid 40082146)
90. Gore DC, Wolf SE, Sanford AP, et al: Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am J Physiol Endocrinol Metab 2004; 286: E529-E534
91. Thomas SJ, Morimoto K, Herndon DN, et al: The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 2002; 132:341-347 (Pubitemid 35024782)
92. Biolo G, De Cicco M, Lorenzon S, et al: Treating hyperglycemia improves skeletal muscle protein metabolism in cancer patients after major surgery. Crit Care Med 2008; 36:1768-1775
93. Shen CA, Chai JK, Yao YM, et al: [Effect of insulin intensive treatment on hyperproteolysis of skeletal muscle in scalded rabbit with sepsis], Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006; 18:139-142
94. LanoneS,MebazaaA,HeymesC,etal:Muscularcontractilefailureinsepticpatients: roleoftheinduciblenitricoxidesynthasepathway.AmJRespirCritCareMed2000;162: 2308-2315(Pubitemid32051705)
95. Ellger B, Richir MC, van Leeuwen PA, et al: Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity. Endocrinology 2008, 149:3148-3157 (Pubitemid 351724509)
96. Nijveldt RJ, Teerlink T, van Leeuwen PA: The asymmetrical dimethylarginine (ADMA)multiple organ failure hypothesis. Clin Nutr 2003; 22:99-104 (Pubitemid 36193187)
97. Siroen MP, van Leeuwen PA, Nijveldt RI, et al: Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: A possible explanation of reduced morbidity and mortality? Crit Care Med 2005; 33:504-510
98. Langouche L, Van den Berghe G: Glucose metabolism and insulin therapy. Crit Care Clin 2006; 22:119-129, vii